These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25546746)

  • 1. The relevance of collaborative work: the Latin American Society for Immunodeficiencies (LASID) registry model.
    Condino-Neto A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):16-7. PubMed ID: 25546746
    [No Abstract]   [Full Text] [Related]  

  • 2. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID).
    Condino-Neto A; Sorensen RU; Gómez Raccio AC; King A; Espinosa-Rosales FJ; Franco JL
    Allergol Immunopathol (Madr); 2015; 43(5):493-7. PubMed ID: 25294607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary immunodeficiency diseases in Latin America: proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board.
    Leiva LE; Bezrodnik L; Oleastro M; Condino-Neto A; Costa-Carvalho BT; Grumach AS; Espinosa-Rosales FJ; Franco JL; King A; Inostroza J; Quezada A; Porras O; Sorensen RU
    Allergol Immunopathol (Madr); 2011; 39(2):106-10. PubMed ID: 21345576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases.
    Costa-Carvalho B; González-Serrano M; Espinosa-Padilla S; Segundo G
    Expert Rev Clin Immunol; 2017 May; 13(5):483-489. PubMed ID: 27797286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives.
    Condino-Neto A; Franco JL; Espinosa-Rosales FJ; Leiva LE; King A; Porras O; Oleastro M; Bezrodnik L; Grumach AS; Costa-Carvalho BT; Sorensen RU
    Allergol Immunopathol (Madr); 2012; 40(3):187-93. PubMed ID: 22445276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.
    França TT; Barreiros LA; Salgado RC; Napoleão SMDS; Gomes LN; Ferreira JFS; Prando C; Weber CW; Di Gesu RSW; Montenegro C; Aranda CS; Kuntze G; Staines-Boone AT; Venegas-Montoya E; Becerra JCA; Bezrodnik L; Di Giovanni D; Moreira I; Seminario GA; Raccio ACG; Dorna MB; Rosário-Filho NA; Chong-Neto HJ; de Carvalho E; Grotta MB; Orellana JC; Dominguez MG; Porras O; Sasia L; Salvucci K; Garip E; Leite LFB; Forte WCN; Pinto-Mariz F; Goudouris E; Nuñez MEN; Schelotto M; Ruiz LB; Liberatore DI; Ochs HD; Cabral-Marques O; Condino-Neto A
    J Clin Immunol; 2022 Apr; 42(3):514-526. PubMed ID: 34982304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.
    Weller S; Faili A; Garcia C; Braun MC; Le Deist F F; de Saint Basile G G; Hermine O; Fischer A; Reynaud CA; Weill JC
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1166-70. PubMed ID: 11158612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases.
    Zelazko M; Carneiro-Sampaio M; Cornejo de Luigi M; Garcia de Olarte D; Porras Madrigal O; Berrón Perez R; Cabello A; Rostan MV; Sorensen RU
    J Clin Immunol; 1998 Mar; 18(2):161-6. PubMed ID: 9533660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
    Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
    Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
    Lougaris V; Badolato R; Ferrari S; Plebani A
    Immunol Rev; 2005 Feb; 203():48-66. PubMed ID: 15661021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful outcome in two patients with CD40 deficiency treated with allogeneic HCST.
    Al-Dhekri H; Al-Sum Z; Al-Saud B; Al-Mousa H; Ayas M; Al-Muhsen S; Arnaout R; Al-Seraihy A; Hawwari A; Al-Ghonaium A
    Clin Immunol; 2012 Apr; 143(1):96-8. PubMed ID: 22342113
    [No Abstract]   [Full Text] [Related]  

  • 13. The revolution in molecular biology leads to new understanding of the clinical expression of immunodeficiencies.
    John CC; Schreiber JR
    J Pediatr; 2003 Feb; 142(2):99-101. PubMed ID: 12584526
    [No Abstract]   [Full Text] [Related]  

  • 14. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human B cell growth and differentiation: lessons from the primary immunodeficiencies.
    Callard RE; Smith SH; Matthews DJ
    Chem Immunol; 1997; 67():114-32. PubMed ID: 9212502
    [No Abstract]   [Full Text] [Related]  

  • 17. Abstracts of the LASID (Latin American Society for Immunodeficiencies) Meeting 2013. October 17-19, 2013. Santiago, Chile.
    J Clin Immunol; 2013 Sep; 33 Suppl 3():S105-39. PubMed ID: 23996460
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel hypomorphic mutation in STIM1 results in a late-onset immunodeficiency.
    Schaballie H; Rodriguez R; Martin E; Moens L; Frans G; Lenoir C; Dutré J; Canioni D; Bossuyt X; Fischer A; Latour S; Meyts I; Picard C
    J Allergy Clin Immunol; 2015 Sep; 136(3):816-819.e4. PubMed ID: 25935105
    [No Abstract]   [Full Text] [Related]  

  • 19. CD154 and type-1 cytokine response: from hyper IgM syndrome to human immunodeficiency virus infection.
    Subauste CS
    J Infect Dis; 2002 Feb; 185 Suppl 1():S83-9. PubMed ID: 11865444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Society for Immunodeficiencies (ESID) registry 2014.
    Grimbacher B;
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):18-20. PubMed ID: 25546747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.